G AND W LABS INC
GenericsG AND W LABS INC is a generic drug manufacturer focused on Neurology, Dermatology, Immunology.
G AND W LABS INC's Key Drugs
G AND W LABS INC's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
G AND W LABS INC's Recent FDA Approvals
New NDA/BLA approvals for G AND W LABS INC over the last two years — novel drugs only, excluding generics and label supplements.
G AND W LABS INC's Therapeutic Areas
G AND W LABS INC's approved drugs and pipeline span 4 therapeutic areas, led by Neurology and Dermatology. Weighted by commercial stage — approved drugs count most, then late-stage trials.
G AND W LABS INC's Top Competitors
G AND W LABS INC's closest competitors by therapeutic-area and drug-target overlap include Pfizer, Eli Lilly, and Bristol-Myers Squibb. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
G AND W LABS INC Pipeline Snapshot
Active clinical trials for G AND W LABS INC across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Neurology pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 1982-07-14
- Latest
- 2019-07-05
- Applications
- 12